Evidence map›Paper›PMID 24997360›Full record

ArticleDevelopmental biology2014

Inhibition of RHO-ROCK signaling enhances ICM and suppresses TE characteristics through activation of Hippo signaling in the mouse blastocyst.

Kanako Kono, Dana Ann A Tamashiro, Vernadeth B Alarcon

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Signaling pathway regulators in preimplantation embryos.Journal of molecular histology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Early embryonic lethality of mice lacking POLD2.Molecular reproduction and development · 2023
    Article
  16. Review
  17. Review
  18. Rho Kinases in Embryonic Development and Stem Cell Research.Archivum immunologiae et therapiae experimentalis · 2022
    Review
  19. Article
  20. From Mice to Men: Generation of Human Blastocyst-Like StructuresFrontiers in cell and developmental biology · 2022
    Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kanako KonoInstitute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA.
Dana Ann A TamashiroInstitute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA.
Vernadeth B AlarconInstitute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA. Electronic address: vernadet@hawaii.edu.
University of Hawaiʻi at Mānoa · US

Funding

Transgenic Mouse, ICSI and IVF CoreP20GM103457 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI WARD, WILLIAM S · 2012 to 2018
$12.9M
NIGMS NIH HHS P20 GM103457NIGMS NIH HHS P20GM103457
6 · The paper itself

Abstract

Specification of the trophectoderm (TE) and inner cell mass (ICM) lineages in the mouse blastocyst correlates with cell position, as TE derives from outer cells whereas ICM from inner cells. Differences in position are reflected by cell polarization and Hippo signaling. Only in outer cells, the apical-basal cell polarity is established, and Hippo signaling is inhibited in such a manner that LATS1 and 2 (LATS1/2) kinases are prevented from phosphorylating YAP, a key transcriptional co-activator of the TE-specifying gene Cdx2. However, the molecular mechanisms that regulate these events are not fully understood. Here, we showed that inhibition of RHO-ROCK signaling enhances ICM and suppresses TE characteristics through activation of Hippo signaling and disruption of apical-basal polarity. Embryos treated with ROCK inhibitor Y-27632 exhibited elevated expression of ICM marker NANOG and reduced expression of CDX2 at the blastocyst stage. Y-27632-treated embryos failed to accumulate YAP in the nucleus, although it was rescued by concomitant inhibition of LATS1/2. Segregation between apical and basal polarity regulators, namely PARD6B, PRKCZ, SCRIB, and LLGL1, was dampened by Y-27632 treatment, whereas some of the polarization events at the late 8-cell stage such as compaction and apical localization of p-ERM and tyrosinated tubulin occurred normally. Similar abnormalities of Hippo signaling and apical-basal polarization were also observed in embryos that were treated with RHO GTPases inhibitor. These results suggest that RHO-ROCK signaling plays an essential role in regulating Hippo signaling and cell polarization to enable proper specification of the ICM and TE lineages.

Indexed as

Adaptor Proteins, Signal TransducingAmidesAnimalsBlastocyst Inner Cell MassCDX2 Transcription FactorCell Cycle ProteinsCell DifferentiationCell LineageCell PolarityCytoskeletal ProteinsEctodermEnzyme InhibitorsGene Expression Regulation, DevelopmentalHippo Signaling PathwayHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsAdaptor Proteins, Signal TransducingAmidesCdx2 protein, mouseCDX2 Transcription FactorCell Cycle ProteinsCytoskeletal ProteinsEnzyme InhibitorsHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsLats1 protein, mouseLATS2 protein, mouseLlgl1 protein, mouseNanog Homeobox ProteinNanog protein, mousePhosphoproteinsProtein Kinase CProtein Kinase C zetaProtein Serine-Threonine KinasesPyridinesrho-Associated Kinasesrho GTP-Binding ProteinsRNA, Small Interferingscrib protein, mouseTranscription FactorsTumor Suppressor ProteinsY 27632Yap1 protein, mouseYAP-Signaling ProteinsCDX2Cell lineageCell polarityInner cell massTrophectodermYAP

Identifiers

PMID24997360
PMCPMC4404313
OpenAlexW1980426094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.